Business
Cannabics Pharmaceuticals to Co-Sponsor the Canada Cannabis House at the World Economic Forum in Davos
Cannabics Pharmaceuticals to Co-Sponsor the Canada Cannabis House at the World Economic Forum in Davos.
About this update from Cnbx Pharmaceuticals Inc.
[{"type":"text","content":"\n\n\n\nCannabics Pharmaceuticals to Co-Sponsor the Canada Cannabis House at the World Economic Forum in Davos\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nCannabics Pharmaceuticals to Co-Sponsor the Canada Cannabis House at the World Economic Forum in Davos\nPR Newswire\nTEL AVIV, Israel and BETHESDA, Maryland, Jan. 22, 2019\n\n\n\n\n TEL AVIV, Israel and BETHESDA, Maryland, Jan. 22, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced that Mr. Eyal Barad, Co-Founder and CEO, and Dr. Eyal Ballan, Co-Founder and CTO, will be in Davos, Switzerland in January, 2019. They will attend the World Economic Conference as part of the CannaTech Davos at Canada Cannabis House Pavilion, hosted in collaboration with the Canadian Securities Exchange and OTC Markets.\n\n \n \n\n \nCannabics CEO Eyal Barad will be featured in the panel \"Exporting Cannabis Innovation to the World from Israel\" Forum, on Thursday January 24th, from 4:00pm to 6:00pm.\n\"We are pleased to be attending an event of this global scale, which affords us the opportunity of presenting our technology one on one to world leaders and the most highly respected group of political, NGO and business executives\", said Mr. Eyal Barad. \"We hope to be able to leverage our participation in the Forum to bring to light the importance of Cannabis both economically and therapeutically and continue our mission of bringing Cannabinoid based therapies to regulated modern medicine.\"\nThe Canada Cannabis House will feature sessions with distinguished group of speakers, including Mr. Ehud Barak, Former Israeli Prime Minister and Chairman of InterCure; as well as Mr. Roei Zerahia, CEO of Canndoc; Mr. Yona Levy, CEO of Alvit and Tefen; Mr. Lorne Gertner, Chairman of Hiku Brands; Mr. Jason Warnock, CEO of TheraCann; and Mr. Saul Kaye, CEO of iCAN, Israel Cannabis.\nSaul Kaye noted, \"I am thrilled that CannaTech will be co-hosting the Canada Cannabis House along with the Canadian Securities Exchange (CSE), OTC markets,...